| View |
|
DRP-10004
|
Pravastatin (as Sodium)
|
Pravaz
|
20 mg
|
Tablet
|
HMG-CoA Reductase Inhibitor/Antihyperlipidemic
|
Amherst Laboratories, Inc
|
Philippines
|
Renewal
|
05 May 2024
|
06 August 2029
|
| View |
|
DRP-10534-02
|
Celecoxib
|
Vecox
|
200 mg
|
Capsule
|
Non-steroidal Anti-inflammatory Drug (COX-2 Selective Inhibitor)
|
Kopran Limited
|
India
|
CLIDP Conversion
|
05 May 2024
|
12 October 2026
|
| View |
|
DRP-10637-01
|
Azithromycin (as dihydrate)
|
Zitrom IV
|
500 mg
|
Lyophilized Powder for Injection (I.V.)
|
Antibacterial (Macrolide)
|
Kilitch Drugs (India) Ltd.
|
India
|
CLIDP Conversion
|
06 May 2024
|
26 October 2026
|
| View |
|
DRP-10782-03
|
Epinephrine
|
Epifed
|
1 mg/mL
|
Solution for Injection (I.M./S.C./I.V.)
|
Adrenergic Agent (Alpha and Beta-adrenoreceptor Agonist)
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
CLIDP Conversion
|
06 May 2024
|
18 November 2026
|
| View |
|
DRP-10946-04
|
Gentamicin (as sulfate)
|
None
|
3 mg/mL (0.3% w/v)
|
Ophthalmic/ Otic Solution (Drops)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
CLIDP Conversion
|
06 May 2024
|
21 December 2026
|
| View |
|
DRP-11260-01
|
Enzalutamide
|
Xzamide
|
40 mg
|
Capsule
|
Anti-androgen (Androgen Receptor Antagonist)
|
BDR Pharmaceuticals International Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 May 2024
|
18 February 2027
|
| View |
|
DRP-11361-04
|
Cefuroxime (as sodium)
|
Goxcefuro
|
750 mg
|
Powder for injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
06 May 2024
|
04 March 2027
|
| View |
|
DRP-11459-01
|
Gabapentin
|
Tranquilyte
|
300 mg
|
Capsule
|
Antiepileptic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
06 May 2024
|
15 March 2027
|
| View |
|
DRP-11898-05
|
Ceftriaxone (as sodium)
|
Gotrione
|
1g
|
Powder for injection (IM/IV)
|
Antibacterial (Third-generation cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
06 May 2024
|
18 May 2027
|
| View |
|
DRP-12160-01
|
Aceclofenac
|
Ceclofam
|
100mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
ACME Formulations Pvt. Ltd
|
India
|
CLIDP Conversion
|
06 May 2024
|
24 June 2027
|
| View |
|
DRP-12191-01
|
Loratadine
|
Loranix
|
10 mg
|
Chewable Tablet
|
Antihistamine
|
Ratnatris Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 May 2024
|
28 June 2027
|
| View |
|
DRP-12333-02
|
Diosmin+ Hesperidin
|
Flavos
|
900mg/100mg
|
Tablet
|
Vasoprotective
|
Saga Lifescience Limited
|
India
|
CLIDP Conversion
|
06 May 2024
|
20 July 2027
|
| View |
|
DRP-12528-03
|
Celecoxib
|
Medibrex
|
200 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Ratnatris Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
06 May 2024
|
26 August 2027
|
| View |
|
DRP-12544-01
|
Azithromycin (as dihydrate)
|
Gozirox
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
AMN Life Pvt. Ltd.
|
India
|
CLIDP Conversion
|
02 May 2024
|
31 August 2027
|
| View |
|
DRP-12544-03
|
Azithromycin (as dihydrate)
|
Zebazith
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
AMN Life Pvt. Ltd.
|
India
|
CLIDP Conversion
|
07 May 2024
|
31 August 2027
|
| View |
|
DRP-12575-02
|
Ursodeoxycholic Acid
|
Urzokolix
|
250 mg
|
Film-Coated Tablet
|
Bile and Liver Therapy (Bile acids and derivative)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 May 2024
|
06 September 2027
|
| View |
|
DRP-12601-08
|
Febuxostat
|
Fixuric 40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
06 May 2024
|
14 September 2027
|
| View |
|
DRP-12730-02
|
Citicoline (as sodium)
|
Xytam
|
250 mg/mL (1 g /4 mL)
|
Solution for Injection
|
Psychostimulant and Nootropic
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
10 May 2024
|
29 September 2027
|
| View |
|
DRP-12735-07
|
Telmisartan + Amlodipine (as besilate)
|
Corvita 80/10
|
80 mg / 10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
10 May 2024
|
30 September 2027
|
| View |
|
DRP-12736-07
|
Telmisartan + Amlodipine (as besilate)
|
Corvita 40/10
|
40 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
10 May 2024
|
30 September 2027
|